New Drug Development for Schizophrenia

Mon Dec 17, 2018
This presentation by Oliver Freudenreich, MD, FACLP, Co-Director of the Schizophrenia Clinical and Research Program at Mass General, was part of Schizophrenia Education Day 2018: Progress in Schizophrenia. The Department of Psychiatry provides free educational programs featuring Mass General clinicians for patients and families facing a variety of mental health challenges. Learn more about these programs: